Skip to main content

Table 2 Demographic and laboratory data of the studied population (n = 117)

From: Can bilirubin/albumin ratio predict neurodevelopmental outcome in severe neonatal hyperbilirubinemia? A 3-month follow up study

Characteristics

 

Male

70 (59.8%)

Gestational age (weeks)

37.8 ± 0.6

Weight (g)

2906 ± 443

Maternal diabetes

4 (3.4%)

Onset of jaundice (days)

2.9 ± 1.35

Age at admission (days)

5.52 ± 2.7

Bilirubin on admission (mg/dl)

25 (22–28.7)

Albumin on admission (g/dl)

3.4 (3.2–3.4)

Bilirubin/albumin ratio (mg/dl)

7.3 (6.4–8.9)

Reticulocyte count %

4.2 (1.7–12)

Positive Coombs test

34 (40%)

Rh Incompatibility

9 (7.69%)

ABO Incompatibility

35 (29.9%)

Suspected Sepsis

2 (1.7 %)

BIND score on admission

 0–3

113

 4–7

4

 Conventional (double) phototherapy

10 (8.5%)

 Intensive phototherapy

107 (91.5%)

 Exchange transfusion

18 (15.4%)

BIND score on discharge

 0–3

116

 4–7 (ABE)

1

Neurological outcome at 3 months

 Normal

105 (89.7%)

 Kernicterus

7 (6%)

 Missed follow up

5 (4.3%)

  1. Sepsis was suspected if there were clinical signs of sepsis associated with positive blood culture OR 2 of the following (a) elevated CRP, (b) total leucocytic count > 25,000 or < 5000, (c) immature to total neutrophil of ratio > 0.2, and (d) band count > 10%